Literature DB >> 423104

Theophylline protein binding in humans.

K J Simons, F E Simons, C J Briggs, L Lo.   

Abstract

Theophylline protein binding was 58-82% in serum from six normal adults and 42 asthmatic patients, 1-25 years old, who were given 5 mg of theophylline/kg. The binding range was greatest in young patients, but the proportion of protein-bound drug did not correlate with age. Theophylline protein binding was higher than previously reported. The effect of binding should be considered in patients who do not have optimal bronchodilation from theophylline despite total serum theophylline concentrations of 10-20 microgram/ml.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 423104     DOI: 10.1002/jps.2600680238

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis.

Authors:  O Brørs; G Sager; D Sandnes; S Jacobsen
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

2.  Monitoring aminophylline therapy using Jusko's dosage guidelines.

Authors:  E P Calandre; A J Perez de la Cruz; A M Morales; N P Alférez; E Moreno; G V Mata
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

3.  Plasma protein binding of dipyrone metabolites in man.

Authors:  E Zylber-Katz; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 5.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

6.  Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.

Authors:  J Blanchard; S Harvey; W J Morgan
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

7.  Determinants of the plasma protein binding of theophylline in health.

Authors:  D Buss; D Leopold; A P Smith; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

8.  Free and total plasma theophylline concentrations in chronic airflow obstruction.

Authors:  P Ebden; D Leopold; A P Smith; D Buss; P A Routledge
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

Review 9.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

10.  Comparative pharmacokinetics of theophylline and aminophylline in man.

Authors:  A Aslaksen; O M Bakke; T Vigander
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.